Amendment to Section 8.4. Section 8.4 of the 2008 Eagle/▇▇▇▇▇▇ Agreement is hereby amended by adding the following sentence: ‘‘Notwithstanding the foregoing, ▇▇▇▇▇▇ and any of its AFFILIATES shall be entitled to develop, manufacture and Commercialize ANDA formulations for its own account in respect of [*].”
Appears in 3 contracts
Sources: Development and License Agreement (Eagle Pharmaceuticals, Inc.), Development and License Agreement (Eagle Pharmaceuticals, Inc.), Development and License Agreement (Eagle Pharmaceuticals, Inc.)